Zileuton Tablet, Film Coated, Extended Release
Product Images NDC 72603-246

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zileuton (NDC 72603-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zileuton-container-label (Zileuton Container Label)

Label for Zileuton Extended-Release Tablets, 600 mg, oral film-coated extended-release tablets supplied by NorthStar RxLLC. The label indicates a 120-tablet bottle, with dosage instructions to take 2 tablets BID. Storage instructions, manufacturing details by Annora Pharma Pvt. Ltd. India, and a barcode are visible.*

FDA Label Image

Zileutonertabfigure (Zileutonertabfigure)

A line graph comparing mean change from baseline in trough FEV1 (L) over a 12-week double-blind study period plus endpoint for Zileuton Extended-Release Tablets versus placebo. The graph shows increments in lung function for both groups, with data points marked for weeks 0, 2, 4, 8, 12, and endpoint, and includes sample sizes (N) for each time point.*

FDA Label Image

Zileutonertabstructure (Zileutonertabstructure)

Chemical structure of Zileuton, showing its molecular arrangement including a benzothiophene ring and hydroxyl, amide, and methyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.